Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC-1204 in APOE4(-) mild to moderate Alzheimer's disease
NCT01211782Phase 3Withdrawn
- Sponsor
- Cerecin
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tricaprilin in Alzheimer's disease (AD), sponsored by Cerecin. Status: withdrawn.
02
Drugs
tricaprilin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01211782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01211782.